Device Survival Probability
| 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | at 62 mo | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| % |  |
100.0 | 99.9 | 99.6 | 99.2 | 99.1 | 99.1 | ||||
| % |  |
99.7 | 98.2 | 92.5 | 74.8 | 19.9 | 1.8 | ||||
| # | 16898 | 14754 | 11815 | 7487 | 1069 | 262 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Advisories For This Model
- There are no advisories for this model.
Product Characteristics
| Generator Type | CRT-Defib |
|---|---|
| NBD Code | VVED |
| Max. Delivered Energy | 35 J |
| Connector Style | CRT-D Style |
|---|---|
| Serial Number Prefix | PRL |
| Mass | 78 g |
| Volume | 40 cc |
| Waveform | Biphasic |
| X-Ray ID | PRL |
Estimated Longevity
| Charging Frequency | 100% Pacing | 50% Pacing | 15% Pacing | 100% Sensing |
|---|---|---|---|---|
| Monthly | 3.3 | 3.8 | 4.1 | 4.3 |
| Quarterly | 4.5 | 5.3 | 6.2 | 6.6 |
| Semi-annual | 5.0 | 6.0 | 7.1 | 7.7 |
Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Intergrated bi-ventricular pacing RV+LV; Left Ventricle Impedance 510ohms; Left Ventricular Pulse Width 0.4ms; Left Ventricular Pulse Amplitude 3V; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content
EOL Indication
From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.
Distribution Data
| US Market Release | 2005-04-08 |
|---|---|
| CE Approval Date | 2005-01-14 |
| Registered USA Implants | 18953 |
| Estimated Active USA Implants | 2000 |
| Normal Battery Depletions | 5150 |
| US Market Release | 2005-04-08 |
|---|---|
| CE Approval Date | 2005-01-14 |
| Estimated WW Distribution | 30906 |
| Normal Battery Depletions | 5239 |
Malfunctions (USA)
| Therapy Function Not Compromised | 106 |
|---|---|
| Battery | 1 |
| Electrical Component | 13 |
| Possible Early Battery Depletion | 89 |
| Other | 3 |
| Therapy Function Compromised | 5 |
| Electrical Component | 4 |
| Other | 1 |
Malfunctions (WW)
| Therapy Function Not Compromised | 143 |
|---|---|
| Battery | 1 |
| Electrical Component | 34 |
| Possible Early Battery Depletion | 100 |
| Other | 8 |
| Therapy Function Compromised | 11 |
| Electrical Component | 10 |
| Other | 1 |
Elective Replacement (ERI)
Battery voltage less than 2.62 V or Charge Time greater than 16 seconds.
Charge Time
Data as of March 12, 2013